resencatinib   Click here for help

GtoPdb Ligand ID: 12381

Synonyms: Example 152 [WO2020228756A1]
Compound class: Synthetic organic
Comment: This is the chemical structure for the INN resencatinib. The structure is claimed in patent WO2020228756A1, as a RET receptor tyrosine kinase inhibitor [1]. RET is a proto-oncogene that's implicated in the development of many cancers (including breast cancer, gastric cancer, bowel cancer, thyroid carcinomas, NSCLC, and chronic myelomonocytic leukemia), and its inhibition is a validated anti-tumour mechanism.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 8
Topological polar surface area 112.04
Molecular weight 535.23
XLogP 3.62
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C#C[C@](COc1cn2ncc(c2c(c1)c1ccc(nc1)N1CC2CC(C1)N2Cc1ccc(nc1)OC)C#N)(O)C
Isomeric SMILES C[C@](COc1cn2c(c(cn2)C#N)c(c1)c1cnc(cc1)N1CC2CC(C1)N2Cc1cnc(cc1)OC)(C#C)O
InChI InChI=1S/C30H29N7O3/c1-4-30(2,38)19-40-25-10-26(29-22(11-31)14-34-37(29)18-25)21-6-7-27(32-13-21)35-16-23-9-24(17-35)36(23)15-20-5-8-28(39-3)33-12-20/h1,5-8,10,12-14,18,23-24,38H,9,15-17,19H2,2-3H3/t23?,24?,30-/m1/s1
InChI Key WNPSOODWDSNATA-DPHZAUTASA-N
Download 2D Structure Click here for help
Canonical SMILES Download
Isomeric SMILES Download
InChI standard identifier Download
InChI standard key Download

Molecular structure representations generated using Open Babel